Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05221294Completed
Randomised, double-blind trial of modified del Nido cardioplegia in coronary artery disease (CAD) and heart valve disease (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Troponin I. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05221294.